Platelet transfusion therapy
- PMID: 8974196
Platelet transfusion therapy
Abstract
Although platelet transfusion is a vital part of modern hemotherapy, many related issues are unresolved. The most appropriate trigger point of transfusion and the clinical utility of prophylactic transfusion are still debated, but the importance of patient-specific transfusion decisions is clear. Leukocyte reduction and single donor platelets may have important roles in avoiding complications, but more data are needed. Establishment of a standardized protocol for managing patients receiving ongoing platelet transfusions may facilitate application of special techniques and the use of specially chosen units that provide better platelet support for thrombocytopenic patients.
Similar articles
-
Platelet transfusion therapy.Hematol Oncol Clin North Am. 2007 Aug;21(4):697-729, vii. doi: 10.1016/j.hoc.2007.06.010. Hematol Oncol Clin North Am. 2007. PMID: 17666286 Review.
-
Optimizing platelet transfusion therapy.Blood Rev. 2004 Sep;18(3):149-65. doi: 10.1016/S0268-960X(03)00057-2. Blood Rev. 2004. PMID: 15183900 Review.
-
Platelet transfusion refractoriness.Br J Haematol. 2008 Jul;142(3):348-60. doi: 10.1111/j.1365-2141.2008.07189.x. Epub 2008 May 28. Br J Haematol. 2008. PMID: 18510692 Review.
-
The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.Vox Sang. 2004 Nov;87(4):291-8. doi: 10.1111/j.1423-0410.2004.00582.x. Vox Sang. 2004. PMID: 15585026
-
Consensus and controversies in platelet transfusion.Transfus Apher Sci. 2009 Oct;41(2):127-33. doi: 10.1016/j.transci.2009.07.004. Epub 2009 Aug 29. Transfus Apher Sci. 2009. PMID: 19717344 Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources